Service of Army dog ‘Axel’, who helped kill terrorist, honoured
PTI, Aug 15, 2022, 8:42 AM IST
New Delhi: Indian Army’s canine soldier ‘Axel’ who was shot dead by a terrorist in an anti-terror operation in Jammu and Kashmir’s Baramulla district last month has been recognised by the government for his service.
Two-year-old Axel’s name figured in the list of the ‘Mention-in-Despatches’ as the government came out with the gallantry awards ahead of Independence Day on Monday. The dog made the supreme sacrifice on July 30 during the anti-terror operation but not before pinpointing the location of a holed-up terrorist and thereby protecting a mosque in the vicinity.
The terrorist was later killed by security forces after an eight-hour-long gunfight in the Wanigam Bala area of Kreeri in Baramulla.
The Army had paid rich tributes to ‘Axel’, a Belgian Malinois. ‘Axel’ is among the list of 42 ‘Mention-in-Despatches’ that recognise distinguished and meritorious service. resident Droupadi Murmu has approved 107 gallantry awards to Armed Forces and Central Armed Police Forces personnel on the eve of Independence Day.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
After Yogi’s ‘batenge, katenge’ slogan, PM pitches for unity with ‘Ek hai, toh safe hai’ message
Bank fraud: ED seizes jewellery, cash worth over Rs 1 cr in raids against Bhopal-based company, directors
No greater feeling than serving those in need: Outgoing CJI D Y Chandrachud
CJI Chandrachud: A legacy of landmark verdicts that shaped society and some controversy too
Akhilesh Yadav attacks BJP on demonetisation anniversary
MUST WATCH
Latest Additions
NSE, BSE to be closed on Nov 20 for Maharashtra assembly polls
After Yogi’s ‘batenge, katenge’ slogan, PM pitches for unity with ‘Ek hai, toh safe hai’ message
24/7 CT Scan Facility Inaugurated at Dr. TMA Pai Rotary Hospital, Karkala
Bengaluru Police Eye Care Project inaugurated
50-60% cancer cases detected in India annually are preventable, say oncologists
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.